Inhibitors of cAMP-phosphodiesterase 4 (PDE 4) exhibit a range of anti-inflammatory/immunosuppressive activities which suggest potential in a wide range of inflammatory and autoimmune diseases.
Inhibitors of cAMP-phosphodiesterase 4 (PDE 4) exhibit a range of anti-inflammatory/immunosuppressive activities which suggest potential in a wide range of inflammatory and autoimmune diseases. 1) Most interest to date has centered on clinical evaluation in asthmatic patients.
On the basis of our studies on the structure-activity relationships of alkylxanthine for PDE 4 isoenzyme inhibitors, 2) we proposed that the interaction between the alkyl group at the 1-position and the oxo group at the 2-or 6-position of the xanthine skeleton was important for these activities, and we discovered the heterocycle[i]-condensed purine, 3,4-dipropyl-4,5,7,8-tetrahydro-3H-imidazo [1,2-i] purin-5-one (1) which showed selective PDE 4-inhibitory activity and lacked some of the adverse reactions of xanthine derivatives. 3) We thought that both the heterocycle-ring fused onto the purine ring and the conversion from a xanthine to a isoguanine skeleton might be important to elicit these activities. On the other hand, in our previous report, 2) alkyl substitution at the 7-position of the xanthine skeleton increased PDE 1-inhibitory activity and decreased PDE 3-inhibitory activity, without changing the PDE 4-inhibitory activity. In this study, we then designed the novel heterocycle [g, h] condensed-purines, 1,4-pyrimido-(2a) 1,4-diazepino-(2b) , and 1,4-diazocino [1,2,3-gh] condensed-purine (2c). In present paper we describe the synthesis of these condensed-purines 2.
We planned at first the synthesis of [g,h] condensedpurines 2 by intramolecular cyclization of 7-aminoalkyl-3-propylpurine-2,4-dione (6) with phosphorus oxychloride, according to the method of Glushkov. 4) Treatment of enprofylline (3) 5) with the respective (N-benzyloxycarbonyl)-aminoalkyl methanesulfonate (4) in the presence of potassium carbonate gave the corresponding [7-(N-benzyloxycarbonyl) aminoalkyl]-3-propylpurine-2,4-diones (5a, b, c) in 68-86% yields. Removal of the benzyloxycarbonyl group of 5a, b, c by catalytic hydrogenation with 20% palladium hydroxide on carbon gave 7-aminoalkyl-3-propylpurine-2,4-diones (6a, b, c). Although Glushkov obtained [g,h] condensed-purines (9a, b) from the reaction of 7-(dialkylaminoalkyl)-3-methylpurine-2,4-diones (8a, b) with phosphorus oxychloride, we could not obtain the desired condensedpurines 2 from 6 under the same conditions because the intermediate (7) degraded during the chlorination-amination reaction (Chart 2).
Vorbrüggen reported that silylation-amination of inosine with hexamethyldisilazane (HMDS) and amine in the presence of a catalyst gave the corresponding adenosines in high yields. 6) However, intramolecular cyclization via silylationamination with HMDS has not been reported previously. Therefore, intramolecular cyclization via silylation-amination was examined as a means of synthesizing 2. Compound 6 was treated with HMDS in the presence of ammonium sulfate or trimethylchlorosilane as catalyst in pyridine at 140°C. As a result, the desired condensed-purine 2b, c (nϭ3, 4) were obtained from 6b, c in 46% and 70% yields, respectively. This reaction involves silylation of the oxo group at the 6-position and amino group, followed by replacement reaction between trimethylsilanol and the amino group in one-pot. However, the same reaction of 6a (nϭ2) led to 11 via dimerization of the intermediate 10a because the alkyl chain of 10a might be too short to allow the intramolecular cyclization. The structures of 2b, c and 11 were assigned on the basis of 1 H-NMR and mass spectral data. For example, the 1 H-NMR spectrum of 2b showed signals at 0.90, 1.81 and 4.07 ppm assignable to the propyl group, and at 2.30, 3.94 and 4.31 ppm assignable to the methylene group of the 1,4-diazepine ring, and at 7.64 and 10.57 ppm indicating aromatic and NH protons, respectively. The mass spectra (MS) of 2b, c showed peaks at m/z 233 (M ϩ ) and 247 (M ϩ ), respectively, however that of 11 showed a peak at m/z 438 (M ϩ ) (Chart 3).
In conclusion, the first syntheses of heterocycle [g,h] condensed-purines 2b and 2c have been first achieved by intramolecular cyclization of 6b, c using HMDS in the presence of ammonium sulfate or trimethylchlorosilane as a catalyst. Although the PDE 4-inhibitory activity of 2b and 2c were evaluated, along with 1 and XT-44 2) in vitro, according to the published methods, 3) 2b and 2c showed no inhibitory activity against PDE 1, PDE 3 or PDE 4 (Table 1) . However, these results indicate that introduction of a heterocycle-ring to the [i]-position of purine is important to elicit PDE 4-inhibitory activity, although [g,h] -condensation removes the inhibitory activities against PDE 1 and PDE 3 isoenzymes.
Experimental
Melting points were measured on a Yanagimoto micro melting point hot stage apparatus and are uncorrected. IR spectra were determined with a Hitachi 270-30 spectrometer and MS were measured with a JEOL-DX300 instrument.
1 H-NMR was recorded on a JEOL-EX90A spectrometer. Chemical shifts are quoted in parts per million (ppm) with tetramethylsilane as an internal standard, and coupling constants (J) are given in hertz (Hz). Micro analyses were performed in the Micro analytical Laboratory of this faculty by Mrs. T. Kuroda. Yields and physicochemical data of the [7-(N-benzyloxycarbonyl) aminoalkyl]-3-propyl-purine-2,4-dione (5), 7-aminoalkyl-3-propylpurine-2,4-dione (6) and the condensed-purines (2b, c) are summarized in Tables 2, 3, 4 and 5, respectively . N-Benzyloxycarbonylaminoalkyl Methanesulfonate (4) General Procedure: To a solution of N-benzyloxycarbonylaminoalkanol 7) (0.01 mol) in CH 2 Cl 2 (30 ml) was added triethylamine (0.012 mol) and methanesulfonyl chloride (0.012 mol) with stirring at 0°C. After the reaction mixture was stirred for 1 h at room temperature, water was added, and the mixture was extracted with AcOEt. The extracts were washed with brine, dried, and evaporated in vacuo. The residue was purified by silica gel column chromatography using hexane-AcOEt (3 : 1) as an eluent to give 4. General Procedure: To a mixture of enprofylline 3 (15.5 mmol) and anhydrous K 2 CO 3 (18.6 mmol) in dimethylformamide (DMF) (60 ml) was added (N-benzyloxycarbonyl)aminoalkyl methanesulfonate 4 (18.6 mmol) at 0°C, the mixture was stirred at room temperature overnight, then concentrated in vacuo. The residue was chromatographed on silica gel using CHCl as an eluent to give 5.
7-Aminoalkyl-3-propylpurine-2,4-dione (6) General Procedure: To a solution of 5 (8 mmol) in MeOH (200 ml) was added 20% palladium hydroxide on carbon (30 mg), and the mixture was shaken under hydrogen (3 atom) for 2 h. The catalyst was removed and the filtrate concentrated in vacuo, and the residue crystallized to yield 6.
Formation of Condensed-Purine (2b, c) General Procedure: To a solution of 6 (2 mmol) and HMDS (1.29 g, 8 mmol) in pyridine (15 ml) was added (NH 4 ) 2 SO 4 (50 mg) or trimethylchlorosilane (2 mmol) and the mixture was stirred at 140°C for 24 h. After cooling and addition of MeOH (20 ml), the reaction mixture was stirred at room temperature for 15 min and concentrated in vacuo. The residue was chromatographed on silica gel using CHCl 3 -MeOH (4 : 1) as an eluent to give 2b, c.
